CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini on Monday, April 29th. As previously communicated, the Immucor assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list are now available on our website.
On July 6, 2018 the FDA released an industry guidance document for transitioning from individual to ...
Reminder test emails for the Health and Human Services (HHS) email notifications for WNV reactives h...
On September 23, 2019, the new CTS Laboratory Information System successfully implemented in Da...
The new online Learning Center with new content can still be found under the “Training” folder on ...
As an organization dedicated to the safety of the world’s blood and plasma supply, Creative Testing...
Seasonal monitoring of epidemic triggers for West Nile Virus (WNV) NAT tested donations will begin J...